Instructions for Use. Wright Medical Technology 1023 Cherry Road Memphis, TN USA

Similar documents
Application Guide for Full-Thickness Wounds

Integra Flowable Wound Matrix

THE WOUND SOLUTION. (Freeze dried Acellular Dermal Matrix) (Cryopreserved Acellular Dermal Matrix)

READ BEFORE USING. Contents:

POSTERIOR LUMBAR FUSION SURGICAL TECHNIQUE USING A BONE VOID FILLER. Magnifuse. Bone Graft

Product Insert ProKera is approved by the US FDA (510K Approval) as a class II medical device.

SYNTHECEL Dura Repair. Assurance and Versatility for Dura Reconstruction.

Wright Medical Technology, Inc Airline Road Arlington, TN phone toll-free

HeliMEND Advanced. Absorbable Collagen Membrane. Instructions for Use

INSTRUCTIONS FOR USE FOR:

ALLOPURE. Bicortical Allograft Wedges Specific for Evans and Cotton Osteotomies SURGICAL TECHNIQUE

NovoSorb BTM. A unique synthetic biodegradable wound scaffold. Regenerating tissue. Changing lives.

CryoVein Femoral Vein. Other Vascular Allograft included (not pictured): CryoVein Saphenous Vein, Double Graft Pack. (non-cannulated) Pulmonary Human

Integra. TenoGlide Tendon Protector Sheet SURGICAL TECHNIQUE

Doc no: IFU/CPL Issue date: Rev no: 00 Rev date: 1

Epicel (cultured epidermal autografts) HDE# BH Patient Information

Chlamydia trachomatis (CHLa)Test Kit

T-PLIF Spacer. An allograft spacer for transforaminal posterior lumbar interbody fusion.

Step-by-Step Instructions For OraQuick HCV Rapid Antibody Test

Doc no: IFU/CC Issue date: Rev no: 04 Rev date:

The following languages are included in this packet:

Technique Guide KISSloc Suture System

INSTRUCTIONS FOR USE AND CARE

I.C.E. Embryo Vitrification Kit

Hepatitis C Virus (HCV) Antibody Test

BONE VOID FILLERS CONTAINING DONATED HUMAN TISSUE The following languages are included in this packet:

DermaSpan Acellular Dermal Matrix. Reinforcement of Ruptured Posterior Tibial Tendon Repair. Surgical Protocol by Charles Zelen, DPM, FACFAS

Duracryl sutures should be selected and implanted depending on the patient condition, surgical experience, suturing technique and wound size.

Table of Contents. Dialysis Port Care Chemotherapy Port Care G-Tube Care Colostomy Bags Wound Dressings

SYNPOR POROUS POLYETHYLENE IMPLANTS. For craniofacial and orbital augmentation and reconstruction

Versatile grafting Solutions

Customized Cranial and Craniofacial Implants. Instructions For Use. 7000revD_Instructions_For_Use. Page 1 of 8

NeuroMend. Collagen Wrap Conduits. Operative Technique

Technique Guide. SynPOR Porous Polyethylene Implants. For craniofacial and orbital augmentation and reconstruction.

THE BUILDING BLOCKS OF BONE FUSION. Medline Demineralized Bone Allografts Safe and Effective Grafting Options

Foot & Ankle. Smart Toe II. Intramedullary Implant. Operative Technique. Foot & Ankle

OSSIX PLUS The Resorbable Collagen Membrane Instructions for Use for OSSIX PLUS

Follicle Dermal Papilla Cells

Chlamydia Rapid Screen Test (RAP-2858) RUO in the USA. Revised 28 Jul 2006

1. Device Description

ALLOGRAFT VESSELS FROM CADAVERIC DONORS: PRESERVATION, USE AND DISPOSAL

Instructions for Use Neulasta (nu-las-tah) (pegfilgrastim) Injection, for subcutaneous use Single-Dose Prefilled Syringe. Plunger rod Used plunger rod

Helicobacter pylori Antigen Test

For the Attention of the Operating Surgeon: IMPORTANT INFORMATION ON THE MATRIXRIB FIXATION SYSTEM

BIOFIBER. Absorbable Biologic Scaffolding Solutions

Integra TenoGlide Tendon Protector Sheet

REVOLVE System Instructional Guide

Yasargil Permanent Aneurysm Clips

Technique Guide Small Bone Fusion System

Device Preparation (all steps to be performed per standard interventional technique)

ANTIBODY SCREENING by Uni-Gold Recombigen HIV

BIOCOLLAGEN TECHNICAL SHEET

CONFORM SHEET. Demineralized cancellous bone

Treponema Pallidum (TP) Antibody Test

PRESCRIBING INFORMATION

CELLPLEX TCP SYNTHETIC CANCELLOUS BONE

Surgical Technique. Poly UHMWPE. Bio Hyaluronic Acid. Advancing Materials. Advancing Outcomes.

Directions For Use. All directions should be read before use

Smart Solutions for Serious Wounds. An advanced bilayer dermal regeneration matrix FDA approved for the treatment of diabetic foot ulcers.

ZADITEN Eye Drops 1.0%

Cervical Solutions. Trinnect. Hydrated Anterior Cervical Spacer System. Surgical Technique Guide

EVOLVE TRIAD BONE SCREWS

Procine sphingomyelin ELISA Kit

RFS. Resorbable Fixation System SURGICAL TECHNIQUE

CATHETER ACCESS KIT. For use with Prometra Programmable Infusion Systems

Peel-Apart Percutaneous Introducer Kits for

MEDICAL DEVICE PATIENT LABEL AUGMENT. Bone Graft

Single Use Curlew TM Multiple Biopsy Forceps

Sputum DNA Collection, Preservation and Isolation Kit 50 Individual Devices

SIDEKICK EZ FRAME EXTERNAL FIXATION SYSTEM The following languages are included in this packet:

P e r i - G u a r d I N S T R U C C I O N E S D E U S O M O D E D E M P L O I... 6 I S T R U Z I O N I P E R L U S O

PATIENT INFORMATION REMEDY ACETABULAR CUP. Overview

Bard CapSure. Technique Guide. Permanent Fixation System SOFT TISSUE REPAIR. Laparoscopic Inguinal, Open and Laparoscopic Ventral Hernia Repair

Pinit Plate Small Bone Fusion System Bone Plate & Screw System

Surgical Technique. Poly UHMWPE. Bio Hyaluronic Acid. Advancing Materials. Advancing Outcomes.

ENG MYCO WELL D- ONE REV. 1.UN 29/09/2016 REF. MS01283 REF. MS01321 (COMPLETE KIT)

AMENDATORY SECTION (Amending WSR , filed 10/10/95, effective 11/10/95)

Follicle Dermal Papilla Cell

Malaria Pf/pan antigen Rapid Test

AXS Catalyst Distal Access Catheter

Innovative Range of Regenerative Solutions

KASM Knee Articulating Spacer Mold. Surgical Summary

CIPROXIN HC Ear Drops

Instructions for Use Enbrel (en-brel) (etanercept) for injection, for subcutaneous use Multiple-dose Vial

SYMBOLOGY. = Manufacturer. = Manufacturing Serial Number. = Manufacturing Lot Number = Catalog Number LOT REF. = Do not resterilize Single Use Only

PHALINX. Hammertoe Fixation SURGICAL TECHNIQUE

CDR Positioning System User Guide

USA Product Label LEGEND / LEGEND MULTI DOSE. (hyaluronate sodium) Injectable Solution LEGEND MULTI DOSE. (hyaluronate sodium) Injectable Solution

DETERMINE SPECIMEN REQUIREMENTS HIV-1/2 Ag/Ab Combo TESTING PROCEDURE

CONFORM FlEX. Demineralized cancellous bone

PRO-V IDS Kit. Bisco. Instructions for Use. Provisional Restorative System

Surgical Technique. Poly UHMWPE. Bio Hyaluronic Acid. Advancing Materials. Advancing Outcomes.

CAREFULLY READ ALL INSTRUCTIONS PRIOR TO USE

Absorbable Woven Polyglycolic Acid Mesh Tube (Absorbable Nerve Conduit Tube) INSTRUCTIONS FOR USE 2 6

Human CD4+T Cell Care Manual

FUSEFORCE. Hand Fixation System SURGICAL TECHNIQUE

Safety Committee Prototypical Safety Program Manual

Transcription:

Instructions for Use Wright Medical Technology 1023 Cherry Road Memphis, TN 38117 USA 1-800-238-7117 Processed from Donated Human Tissue for Wright Medical Technology by LifeCell Corporation One Millennium Way Branchburg, NJ 08876-3876

DESCRIPTION GRAFTJACKET Regenerative Tissue Matrix is donated allograft human dermis, aseptically processed to remove cells and freeze-dried to remove moisture while preserving biologic components and structure of the dermal matrix. The GRAFTJACKET matrix is white to buff colored and is uniform in appearance. The GRAFTJACKET matrix has a distinct basement membrane and dermal surface. (See ORIENTATION.) REGULATORY CLASSIFICATION GRAFTJACKET Regenerative Tissue Matrix is regulated by the US Food and Drug Administration (FDA) as human tissue for transplantation. GRAFTJACKET matrix is processed and marketed in accordance with the FDA s requirements for banked human tissue (21 CFR, Part 1271) and Standards for Tissue Banking of the American Association of Tissue Banks (AATB).GRAFTJACKET matrix is compliant with the AATB Standards for Tissue Banking and the state guidelines of California, Florida, New York, Maryland and Illinois. DONOR SCREENING AND TESTING LifeCell has determined the donor of this tissue graft to be an eligible donor based on the results of donor screening and testing records and thereby declares the tissue to be safe for transplantation. Donor screening includes, but may not be limited to, review of relevant medical records including a current donor risk assessment interview; a physical examination of the donor; laboratory test results; existing coroner and autopsy results; as well as other information pertaining to risk factors for relevant communicable diseases. Comprehensive donor screening and testing is performed on all tissue donors according to FDA regulations and AATB standards. Refer to the Summary of Records label provided with each graft for details of the testing. Samples of the donor skin are tested for and shown to be free of bacterial and fungal pathogens; non-pathogenic skin bacteria may be present. Due to limitations in testing technology, testing and donor screening cannot totally eliminate the risk that human source material will transmit disease. INDICATIONS FOR USE GRAFTJACKET matrix is used to provide supplemental support, protection, and reinforcement of tendon and ligamentous tissue; to be used as a periosteal patch or covering; or for protection and support of bone and tendons in foot & ankle and hand surgery. Each package of GRAFTJACKET matrix is intended for use in one patient, on a single occasion. CONTRAINDICATIONS GRAFTJACKET matrix is contraindicated for use in any patient who is sensitive to any of the antibiotics listed on the package or polysorbate 20. WARNINGS Processing of the tissue, laboratory testing, and careful donor screening minimize the risks of the donor tissue transmitting disease to the recipient patient. As with any processed donor tissue, the GRAFTJACKET matrix cannot be guaranteed to be free of all pathogens. No long-term studies have been conducted to evaluate the carcinogenic or mutagenic potential or reproductive impact of the clinical application of the GRAFTJACKET Regenerative Tissue Matrix. DO NOT sterilize GRAFTJACKET matrix. DO NOT use GRAFTJACKET matrix if either the outer foil bag or the inner (Tyvek ) pouch is perforated or torn. A damaged foil bag or inner (Tyvek ) pouch may result in degradation or contamination of the product. The inner (Tyvek ) pouch that contains the GRAFTJACKET matrix is NOT STERILE; DO NOT PLACE THE INNER (Tyvek ) POUCH IN THE STERILE FIELD. Transfer GRAFTJACKET matrix from packaging aseptically. Do not place either the foil bag or the inner (Tyvek ) pouch in the sterile field. (See INSTRUCTIONS FOR REHYDRATION.) PRECAUTIONS It is the responsibility of the physician to determine the appropriate size and thickness of GRAFTJACKET matrix for each application. Poor general medical condition or any pathology that would limit the blood supply and compromise healing, as well as nonvascular surgical sites, should be considered when selecting patients for implanting GRAFTJACKET matrix as such conditions may compromise successful implantation. Additionally, users should assess the appropriateness of using the GRAFTJACKET matrix in patients diagnosed with autoimmune connective tissue disease. 1 2

It is the responsibility of the healthcare practitioner to maintain recipient records for the purpose of tracing tissue post-implantation. Patient tracking labels are provided for convenience. Use of GRAFTJACKET matrix is limited to specific health professionals (e.g., physicians). Whenever clinical circumstances require implantation in a site that is contaminated or infected, appropriate local and/or systemic anti-infective measures should be taken. Prior to rehydration DO NOT BEND because this may cause the GRAFTJACKET matrix to fracture. DO NOT USE the GRAFTJACKET matrix if it is broken or cracked. DO NOT USE the GRAFTJACKET matrix if prior to rehydration it is not uniformly white to buff in coloration. DO NOT USE the GRAFTJACKET matrix if it has discolored or browned areas. Normal rehydration of GRAFTJACKET matrix is usually accomplished in 10 40 minutes, depending on thickness. Thick grafts may take up to 60 minutes or longer to completely rehydrate. If any hair is visible, remove before implantation. Unused or expired product should be discarded according to local institutional requirements. ADVERSE EFFECTS Potential adverse effects which may result from placement of an implant or graft include, but are not limited to the following: wound or systemic infection; seroma; dehiscence; hypersensitive, allergic or other immune response; sloughing or failure of the graft; and disease transmission. Adverse outcomes potentially attributed to GRAFTJACKET matrix must be reported promptly to Wright Medical Technology. STORAGE Store product at room temperature in its original packaging. The expiration date for the GRAFTJACKET regenerative tissue matrix is recorded on the outer package as year (4 digits) and month (2 digits) and expires on the last day of the month indicated. Expiration date printed on the labeling is valid as long as product is stored at room temperature and in an unopened foil bag. HOW SUPPLIED GRAFTJACKET matrix is packaged aseptically in an inner (Tyvek ) pouch and sealed in an outer foil bag that may be placed into a box carton. GRAFTJACKET matrix is supplied with or without a printed paper backing depending on size, (e.g., GRAFTJACKET SLR and GRAFTJACKET MAXSTRIP do not have a paper backing). Average product thickness range and approximate size are clearly marked on the label located on the outer foil pouch. INSTRUCTIONS FOR REHYDRATION Important: It is the responsibility of the healthcare practitioner to maintain recipient records for the purpose of tracing tissue post-implantation. Patient tracking labels are provided for convenience. Normal rehydration of GRAFTJACKET matrix is usually accomplished in 10 40 minutes, depending on thickness. Thicker grafts may take up to 60 minutes or longer to completely rehydrate. When preparing to use GRAFTJACKET matrix in the operating room, the following rehydration procedure should begin early enough to allow for adequate rehydration prior to intended implantation (See rehydration table on page 5). Equipment required 2 sterile dishes large enough to accommodate the GRAFTJACKET matrix without bending Sterile normal saline or sterile Lactated Ringer s solution that is sufficient to completely submerge the graft Sterile atraumatic forceps Rehydration Steps Step 1 Tear open the foil bag at the notch and remove the inner (Tyvek ) pouch. Keep both the foil bag and the inner (Tyvek ) pouch OUT of the sterile field. Step 2 Peel open the inner (Tyvek ) pouch and aseptically remove the tissue. If a backing is present, do not peel backing at this point in the process. Note: GRAFTJACKET SLR AND GRAFTJACKET MAXSTRIP do not have a paper backing. 3 4

Step 3 Place the tissue in the first dish in the sterile field. Submerge the tissue completely and soak for a minimum of 5 minutes or until the paper backing separates from the GRAFTJACKET matrix. Step 4 Using a sterile gloved hand or forceps, remove and discard the backing once it separates from the tissue. Then, aseptically transfer the tissue to a second bath sufficiently filled with rehydration fluid. Step 5 Submerge completely and soak until the tissue is fully rehydrated (thicker grafts may take up to 60 minutes or longer). When GRAFTJACKET matrix is fully rehydrated, it is soft and pliable throughout. At this stage, it is ready for application to the surgical site. GRAFTJACKET matrix may be aseptically trimmed to required dimensions. Important: Use GRAFTJACKET matrix within 4 hours of rehydration. Approximate Rehydration Times Product 1 st Wash 2 nd Wash Most GRAFTJACKET Matrix Products 5 minutes 5 10 minutes Maximum Force, MaxStrip and SLR 5 minutes Up to 30 minutes MaxForce Extreme 5 minutes Up to 60 minutes or longer Tips Keep GRAFTJACKET matrix fully submerged by weighing it down (e.g., with sterile forceps). Warming saline up to 37 C and using gentle movement of GRAFTJACKET matrix in the solution speeds the rehydration process. However, do not heat saline above 37 C. When rehydrating multiple pieces, ensure the pieces are not overlapping or clumping together as this may slow the rehydration process. Use multiple bowls for each rinse step, if necessary. If you are having a problem with rehydration, gently wipe/rub both sides of the GRAFTJACKET matrix, using a sterile gloved hand, to remove any excess cryo-protectant that may be creating a barrier between the GRAFTJACKET matrix and the rehydration fluid. Considerations If not completely rehydrated, GRAFTJACKET matrix will appear to be of uneven thickness and have a mottled appearance. Antibiotics may be added to the second rehydration solution. Orientation The GRAFTJACKET matrix has a distinct basement membrane (upper) and dermal surface (lower). When applied to the wound bed in a grafting procedure, the dermal side should be placed against the wound bed, with the basement membrane side facing up. When applied as an implant, the dermal side should be placed against the most vascular tissue. Prominent Physical Distinguishing Characteristics BASEMENT MEMBRANE SIDE Dull Rough (Tactile) Buff-Colored Repels Blood Additional procedures for determining orientation DERMAL SIDE (Place facing most vascular tissue) Shiny Smooth (Tactile) White Color Absorbs Blood To determine proper orientation once the graft has been rehydrated, add a drop of blood to both sides of the graft and rinse with rehydration solution. The dermal side will have a bloody appearance where the blood has been absorbed into the graft, whereas the basement membrane side will appear pink. TISSUE TRANSPLANT RETURN RECORD The Tissue Transplant Return Record (TTRR) is attached to the Instructions for Use. Please separate the TTRR from the Instructions for Use and follow the directions provided on the form for completion and return to Wright Medical Technology. 5 6

INQUIRIES Contact Wright Medical Technology Customer Service 1-800-238-7117 for additional information, to place an order, or to report adverse reactions. GRAFTJACKET Regenerative Tissue Matrix is processed by LifeCell Corporation, One Millennium Way, Branchburg, NJ, 08876 USA. LifeCell Corporation holds Canadian registration # 100128. This product and certain methods are covered by U.S. and foreign patents and patents pending. GRAFTJACKET is a registered trademark of Wright Medical Technology. Tyvek is a registered trademark of DuPont. Part No. 121P0129 Rev. L March 2014 LifeCell Corporation 2014 121P0129REVL